The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f
3 min read IF ANYONE CAN MAKE RATTAN hot, it’s Alexander Skarsgård. The actor’s latest film project, about a craftsman who creates a wicker husband (Skarsgård) for a lonely woman (played by Olivia Colman), has been an unlikely hit since its release in theaters last week. But basket weave isn’t the only material Skarsgård’s rocking—he’s
PAGE, Ariz. — Doug Herrera still lives in the house his father built, though his dad died some time ago from cancer. Herrera wonders if that illness could have been linked to pollutants from nearby uranium mining. Now, he worries that a possible new neighbor — a proposed $10 billion mega data center — could
Press release from the Humboldt County Joint Information Center:
Humboldt County’s total case count stands at 282, after two new cases were reported today.
Due to the pace of increasing cases, Public Health yesterday raised Effectiveness of Disease Control to level three on the county’s Alert Level Assessment Tool. While this does not change the overall alert level, currently at three or level orange, Humboldt County Health Officer Dr. Teresa Frankovich called the rise in cases concerning.
“We’ve reported 49 cases just this week alone, and that represents about 17 percent of our total cases since February,” she said. “These developments should deepen our resolve to do everything we can to limit the spread of this virus.”
Dr. Frankovich went on to say, “I’m deeply grateful to the vast majority of our residents who take on this responsibility to protect each other by using all prevention tools at hand such as facial coverings, distancing and neither traveling nor inviting travel by family members and friends. These types of choices really do make a difference for our county.”
The Public Health Laboratory was unable to operate at full capacity today due to a major plumbing problem overnight that flooded part of the lab and caused significant damage to the offices of the Public Health Director and both Public Health Officers. Damages include downed overhead fixtures in one office and a partial ceiling collapse in another. Michele Stephens, Dr. Teresa Frankovich and Dr. Josh Ennis are temporarily relocating within the building while their offices are repaired. Although some operations were impacted, Public Health personnel said, in terms of COVID testing the lab “didn’t skip a beat.”
For the most recent COVID-19 information, visit cdc.gov or cdph.ca.gov. Local information is available at humboldtgov.org or during business hours by contacting [email protected] or calling 707-441-5000.
Humboldt County COVID-19 Data Dashboard: humboldtgov.org/dashboard, Follow us on Facebook: @HumCoCOVID19, Instagram: @HumCoCOVID19, Twitter: @HumCoCOVID19, and Humboldt Health Alert: humboldtgov.org/HumboldtHealthAlert
###
View of the County Health Officer’s office.
=historic data. All data from the Humboldt County Joint Information Center.
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f